Pharma
Healthcare
PAG to acquire over 20% in South-based pharma firm
Asia-focused private equity investor PAG is set to acquire at least 20% stake in Hyderabad-based bulk drug manufacturer Optimus Drugs ......
Economy
Indian shares end unchanged; tech, pharma stocks gain
Indian shares closed flat on Thursday, after moving in a narrow range through the day, with technology and pharma stocks ......
Manufacturing
Piramal Pharma invests $13 mn in Yapan Bio
Piramal Pharma Limited (PPL), on Tuesday, said that it has invested Rs 101.77 crore (around $13 million) in Hyderabad-based Yapan ......
Healthcare
Advent buys ZCL Chemicals, opens exit door for promoters and Morgan Stanley
Private equity firm Advent International has bought bulk drugs maker ZCL Chemicals for Rs 2,000 crore (around $275 million), offering ......
Insights Focus
Healthcare: The BIG Gap
The outbreak of the COVID-19 pandemic highlighted the huge supply-demand gap in the Indian healthcare ecosystem. The World Health Organization ......
Insights Focus
Watch Satish Chander, Partner, True North share crucial insights on healthcare through the investor lens 2020/ 21
At VCCircle’s flagship Healthcare Investment Summit 2020, Satish Chander, Partner, True North spoke with Shalil Gupta, Chief Business Officer, Mosaic ......
Healthcare
PE-backed Shilpa Medicare to acquire pharma firm, pick up 40% stake in another
Shilpa Medicare Ltd, a Hyderabad-based active pharmaceutical ingredients (APIs) and formulations developer, will acquire one pharmaceutical company and pick up ......
Healthcare
Sun Pharma shares tumble following report of regulatory probe
Shares of India’s Sun Pharmaceutical Industries sank more than 10 percent on Monday after a report of a regulatory probe ......
Healthcare
Chronic therapies to drive PE investments in pharma: IQVIA report
Chronic therapies and oncology in particular will be among the key drivers of private equity investments in the Indian pharmaceuticals ......
Finance
Teenage years for PE are over, Indian market has matured: Blackstone's Amit Dixit
Planned exits from private equity investments in India are no longer a major challenge, besides investors are also getting more ......